Lung Transplantation

A successful lung transplant depends on:

  • Properly evaluating the person receiving the donated lung
  • Properly matching the lung donor to the person receiving the lung to assure compatibility between them
  • Expertise in the surgical procedures needed to remove the failing lung and replace it with a donated lung
  • Ongoing monitoring after a lung transplant to prevent rejection of the donated lung or infections.
To measure the quality of care provided to lung transplant patients, Cedars-Sinai Medical Center examines one-month, one-year and three-year survival rates.

The table below highlights both the numbers and percentages of lung transplant patients surviving one month, one year and three years.

In addition, survival rates for lung transplant patients at Cedars-Sinai Medical Center are also compared to survival rates expected for lung transplant patients with similar ages and health conditions.

The data in the table below reflect patients age 12 and older. The one-month and one-year survival rates reflect patients receiving their first transplant between July 1, 2006 and Dec. 31, 2008. The three-year survival rates reflect patients receiving their first transplant between Jan. 1, 2004, and June 30, 2006.

It should be noted that in 2009, for both 30 days and one year, 100% of patients who received a lung transplant survived.

Lung Transplant (Patients Age 12+)Cedars-Sinai Medical Center
Patient Survival for:1 Month1 Year3 Years
For transplants performedJuly 2006 - Dec. 2008July 2006 -Dec. 2008Jan 2004 - June 2006
Number of transplants*424234
Percent of patients surviving at the end of period observed**90.48%64.95%58.82%
Expected, based on national experience***95.68%82.11%65.54%
Cedars-Sinai's survival rates compared to what is expected for similar patientsNot significantly differentNot significantly differentNot significantly different

* Transplants during the time period indicated in the row above.

** Observed survival rates use the Kaplan-Meier method to estimate outcomes for patients for whom complete follow-up is not expected. Because different cohorts are followed for each time period, it is possible for the reported three-year survival to exceed one-year survival.

*** The survival rate that would be expected for the patients served by this center, given the characteristic mix of the recipient and donor (age, disease and blood type, etc.) and the experience of similar patients in the United States as a whole.

print button
WP1